Latest update: 15 September 

The global economy is forecasted to return to pre-crisis levels by the end of 2021 or early 2022. 

According to Statistics South Africa, real GDP in the nation expanded by 1.2% in Q2 2021.


The unemployment rate in OECD nations stood at 6.2% in July 2021, down from 6.4% in June 2021.


World economic growth is projected at 5.7% in 2021 and at 4.5% in 2022, according to HIS Markit.

Impact of Covid-19 on equity indices


Latest update: 08 October

industry development


Currently, there are 5,941 clinical trials for Covid-19 and promising clinical data continues to emerge for Covid-19 vaccines. 


Trial disruption is levelling off, with 1,058 trials still disrupted and 628 pharma/biotech companies and clinical research organisations associated with disrupted trials.

Outsourcers (CROs/CMOs)

Stalled clinical trials created a work vacuum for clinical research organisations (CROs) and contract development and manufacturing organisations but disrupted trials are slowly starting to resume.

Contract manufacturing organisations (CMOs) and excess capacity contract manufacturers with secure supply lines will benefit from a short term boost in generic drugs manufacturing needed to treat Covid-19 patients.

Outsourcing partners must deal with issues surrounding a potential excess of client needs upon initiation of future trials, with guidance from regulatory agencies still pending.

Key pharma market developments

Share this article